From: Patient-reported functional outcome measures and treatment choice for prostate cancer
Rx | Sexual function | Urinary incontinence | Urinary obstruction | Bowel function | |||||
---|---|---|---|---|---|---|---|---|---|
Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | ||
Baseline scores‡ | RP | 56.3 | 54.1, 58.4 | 89.9 | 88.8, 91.0 | 85.9 | 84.8, 87.0 | 93.5 | 92.8, 94.3 |
EBRT | 45.8 | 41.7, 49.9 | 89.5 | 87.3, 91.6 | 82.2 | 79.9, 84.4 | 90.6 | 89.0, 92.2 | |
BT | 61.4 | 54.6, 68.2 | 90.0 | 86.8, 93.2 | 83.1 | 79.7, 86.4 | 91.0 | 88.5, 93.5 | |
AS | 52.8 | 48.4, 57.2 | 88.8 | 86.5, 91.1 | 84.1 | 81.7, 86.4 | 92.3 | 90.6, 94.1 | |
12-month scores¥ | RP | 28.5 | 26.5, 30.6 | 74.4 | 72.5, 76.3 | 91.8 | 90.7, 92.8 | 92.7 | 91.7, 93.6 |
EBRT | 35.0 | 30.0, 39.9 | 88.0 | 84.0, 91.9 | 84.5 | 81.2, 87.8 | 84.7 | 80.5, 89.0 | |
BT | 45.9 | 38.3, 53.6 | 85.0 | 78.4, 91.6 | 84.8 | 80.2, 89.4 | 90.8 | 87.6, 94.1 | |
AS | 35.4 | 28.7, 42.2 | 85.0 | 80.8, 89.2 | 91.6 | 88.7, 94.4 | 90.6 | 88.4, 92.8 | |
Change scores‡ | RP | -28.9 | -31.7, -26.2 | -15.6 | -17.7, -13.5 | 5.6 | 4.2, 6.9 | -0.8 | -1.8, 0.1 |
EBRT | -16.5 | -24.2, -8.8 | -2.2 | -6.5, 2.1 | 2.0 | -2.7, 6.7 | -6.3 | -11.3, -1.2 | |
BT | -17.8 | -27.1, -8.6 | -5.4 | -11.8, 1.1 | 1.7 | -4.5, 7.8 | -1.1 | -4.9, 2.7 | |
AS | -22.1 | -30.0, -14.3 | -5.9 | -10.2, -1.7 | 3.9 | 0.7, 7.0 | -4.4 | -6.6, -2.1 | |
Mean difference¥¥ | RP | reference | |||||||
EBRT | 6.4 | 0.9, 12.0* | 13.6 | 9.0, 18.2*** | -7.2 | –10.7, − 3.8*** | –7.9 | –12.4, − 3.5*** | |
BT | 17.4 | 9.4, 25.5*** | 10.6 | 3.9, 17.3*** | -6.9 | –11.7, − 2.2*** | –1.8 | –5.1, 1.5 | |
AS | 6.9 | –0.5, 14.3 | 10.6 | 5.9, 15.3*** | -0.2 | –3.5, 3.1 | –2.1 | –4.4, 0.2 |